Relevance of C-reactive protein levels in peritoneal dialysis patients

被引:47
|
作者
Fine, A [1 ]
机构
[1] Univ Manitoba, Nephrol Sect, Winnipeg, MB, Canada
关键词
cardiovascular disease; atherosclerosis; coronary artery disease; infection; chronic renal disease;
D O I
10.1046/j.1523-1755.2002.00145.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. C-reactive protein (CRP) levels are increased in 30 to 50% of dialysis patients and predict cardiovascular morbidity and mortality. It is usually considered that raised CRP levels reflect underlying atherosclerosis. However, many patients may have clinically apparent cardiovascular disease without raised CRP levels. This study was designed to assess both the risk factors for high CRP levels and the usefulness of the test as a marker of clinically apparent coronary artery disease (CAD), peripheral vascular disease (PVD) and the presence of ongoing infections/inflammatory disorders (INF-INFL) in peritoneal dialysis patients. Methods. A chart review of 190 prevalent peritoneal dialysis patients was performed. CRP, albumin, ferritin, erythropoietin (EPO) dose and resistance, Kt/V, and residual renal function values were obtained and a history or presence of cardiovascular disease (CAD, PVD) and presence of INF-INFL recorded. Data were analyzed by Chi-square, Spearman correlation and logistic regression. Results. A total of 31% of patients had a raised CRP. INF-INFL was highly predictive of raised CRP levels (OR 16.97; 95% CI 5.41 to 53.14, P = 0.000), whereas CAD and PVD either singly or in combination had no such association. The sensitivity/specificity for CRP as a test for INF-INFL was 83/77%. For CAD and PVD, the sensitivities were less than 40% and specificities 70%. Increased CRP values were more common in females but not in diabetics. Weak linear correlations existed between CRP levels and albumin, ferritin and residual renal function (r = -0.212, 0.228 and -0.163 respectively P < 0.02). By regression analysis, INF-INFL predicted high CRP levels, but CAD and PVD did not. The majority of patients (57%) with high CRP had no identifiable cause; 40% of these patients had subsequent or previous normal CRP values. High transport status predicted high CRP levels (OR 7.28; 95% CI 1.417 to 37.36, P = 0.006). Conclusions. The majority of elevated CRP levels in peritoneal dialysis patients occur without an obvious cause. Clinically apparent cardiovascular disease does not predict high CRP levels. CRP levels vary over time in the same patient, from normal to high or vice versa, for no obvious reason. Sources of inflammation other than CAD, PVD and clinically obvious INF-INFL in peritoneal dialysis patients remain to be identified.
引用
收藏
页码:615 / 620
页数:6
相关论文
共 50 条
  • [11] Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients?
    Wang, AYM
    Woo, J
    Lam, CWK
    Wang, M
    Sea, MMM
    Lui, SF
    Li, PKT
    Sanderson, J
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (07): : 1871 - 1879
  • [12] Serum C-reactive protein: A predictor of mortality in continuous ambulatory peritoneal dialysis patients
    Noh, H
    Lee, SW
    Kang, SW
    Shin, SK
    Choi, KH
    Lee, HY
    Han, DS
    PERITONEAL DIALYSIS INTERNATIONAL, 1998, 18 (04): : 387 - 394
  • [13] Determinants of C-reactive protein in chronic hemodialysis patients: Relevance of dialysis catheter utilization
    Hung, Adriana
    Pupim, Lara
    Yu, Chang
    Shintani, Ayumi
    Siew, Edward
    Ayus, Carlos
    Hakim, Raymond M.
    Ikizler, Talat Alp
    HEMODIALYSIS INTERNATIONAL, 2008, 12 (02) : 236 - 243
  • [14] Significance of high C-reactive protein levels in pre-dialysis patients
    Ortega, O
    Rodriguez, I
    Gallar, P
    Carreño, A
    Ortiz, M
    Espejo, B
    Jimenez, J
    Gutierrez, M
    Oliet, A
    Vigil, A
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (06) : 1105 - 1109
  • [15] Rosiglitazone reduces insulin requirement and C-reactive protein levels in type 2 diabetic patients receiving peritoneal dialysis
    Wong, TYH
    Szeto, CC
    Chow, KM
    Leung, CB
    Lam, CWK
    Li, PKT
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (04) : 713 - 719
  • [16] Chronic induction of C-reactive protein by hemodialysis, but not by peritoneal dialysis therapy
    Haubitz, M
    Brunkhorst, R
    Wrenger, E
    Froese, P
    Schulze, M
    Koch, KM
    PERITONEAL DIALYSIS INTERNATIONAL, 1996, 16 (02): : 158 - 162
  • [17] C-reactive protein and anemia: Implications for patients on dialysis
    Breiterman-White, Randee
    NEPHROLOGY NURSING JOURNAL, 2006, 33 (05) : 555 - 558
  • [18] Association between C-reactive protein and mortality in peritoneal dialysis patients: a meta-analysis
    Shen, Hongxia
    Chang, Xinwei
    Zheng, Xiao
    Du, Wenting
    Zhao, Beibei
    Wang, Wenjuan
    Lou, Xiaoping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (09): : 17579 - 17587
  • [19] Serum C-reactive protein: A predictor of mortality in continuous ambulatory peritoneal dialysis patients.
    Noh, HJ
    Shin, SK
    Lee, IH
    Kang, SW
    Choi, KH
    Lee, HY
    Han, DS
    KIDNEY INTERNATIONAL, 1998, 54 (05) : 1803 - 1804
  • [20] The relationship of prealbumin (palb) and C-reactive protein (CRP) in peritoneal dialysis (PD) patients (pts).
    Fein, PA
    Reddy, A
    Mittman, N
    Avram, MM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 203A - 203A